Catalyst Wire Dossier Catalyst Wire Dossier

ferucarbotran (Resovist)

ferucarbotran
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ferucarbotran (Resovist), covering 2014-11-07 to 2014-11-07. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran [Phase 2, Phase 3]

See pricing